Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
about
apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290.Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation.High-density lipoprotein: a novel target for antirestenosis therapyApolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis.Cyclooxygenase products and atherosclerosisApolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis.High-density lipoprotein: what is the best way to measure its antiatherogenic potential?Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wallStructure-function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells.Comparative proteomic analysis of rat aorta in a subtotal nephrectomy model.
P2860
Q33825134-91E5F2C2-2127-4EF4-B782-963423E2CE52Q34122180-29737282-47D3-44F3-9B75-E4E87963DF13Q34537514-AAEF9B77-357E-4675-A5B9-BD3ADA627736Q34622857-0F7595C6-2E84-4D33-9F04-60A397215A31Q34714464-4A62BAAA-23D6-4BD7-914C-7E203930B5F1Q35661903-2EB1D85C-9300-4F16-9EB1-B2ADD911FBFEQ35897048-86DF82EF-B846-4753-B094-468C30F659E0Q36800668-88C51CB4-31EC-40BA-B659-DE9CF15023D8Q36888350-DF1F4128-17F5-4E71-869B-3A3F108ED6D8Q37071164-165A9BC9-C9B8-45B7-8725-5969E02040FDQ37693885-735E6F35-8D35-4331-B101-AD0D144ADA8EQ38089776-5F9DCBA0-3222-4FF7-BF1D-E10DEFF09DB9Q41929558-99D5616E-9AE1-472D-B8D0-74CABCA261D6Q42019558-CAC08219-791C-4728-A814-89BA247D06BBQ42541410-2B8155D6-3E6E-41E5-8CF3-04807FB56A6BQ43092547-7B51B0C9-82EA-4B94-A436-79E32F6C01D0
P2860
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
@ast
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
@en
type
label
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
@ast
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
@en
prefLabel
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
@ast
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
@en
P2093
P2860
P356
P1476
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
@en
P2093
Daniel J Rader
David Kwiatkowski
Devashish Kothapalli
Elizabeth A Hawthorne
Ellen Puré
Garret A FitzGerald
Kamilah Ali
Liang Zhao
Michael C Phillips
P2860
P304
P356
10.1172/JCI19097
P407
P577
2004-02-01T00:00:00Z